793 TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) human papilloma virus (HPV)-16+ cancers: clinical efficacy and immunogenicity

Christophe Le Tourneau; Philippe Cassier; Frederic Rolland; Sébastien Salas; Jean Marc Limacher; Olivier Capitain; Olivier Lantz; Ana Lalanne; Christina Ekwegbara; Annette Tavernaro; Hakim Makhloufi; Kaidre Bendjama; Jean-Pierre Delord

doi:10.1136/jitc-2020-SITC2020.0793

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

Late-breaking abstracts

Clinical trials completed

793 TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) human papilloma virus (HPV)-16+ cancers: clinical efficacy and immunogenicity

Main menu

Online download statistics by month:

Online download statistics by month:

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month:

Read the full text or download the PDF:

Log in using your username and password